16:33 - 29.07.2021
July 29, Fineko/abc.az. American pharmaceutical company Pfizer has raised the forecast of sales revenue that they will receive this year from vaccine against a new type of coronavirus (Covid-19), developed by German company BioNTech, from $26 bn up to $33.5 bn.
ABC.AZ reports that in May Pfizer announced that it plans to earn $26 bn this year from sales of vaccines.
According to the company, Pfizer's revenue in the 2nd quarter of this year (Apr-Jun) increased by 92% (versus same term of 2020) up to $19 bn.
Company's sales for the same period of 2020 amounted to $9.9 bn.
26 April 2024
26 April 2024
26 April 2024
26 April 2024
26 April 2024
26 April 2024
26 April 2024
26 April 2024
26 April 2024
26 April 2024
26 April 2024
26 April 2024
26 April 2024
26 April 2024
26 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
25 April 2024
24 April 2024
25 April 2024
24 April 2024
24 April 2024